Dr. Eva Morava-Kozicz, MD, PhD
Claim this profileMore about Eva Morava-Kozicz, MD, PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Eva Morava-Kozicz, MD, PhD has experience with
- Epalrestat
- Placebo
Breakdown of trials Eva Morava-Kozicz, MD, PhD has run
Congenital Disorder of Glycosylation
Phosphomannomutase 2 Deficiency
Phosphomannomutase II Deficiency
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eva Morava-Kozicz, MD, PhD specialize in?
Eva Morava-Kozicz, MD, PhD focuses on CDG and Congenital Disorder of Glycosylation. In particular, much of their work with CDG has involved PMM2 positive patients, or patients who are undergoing treatment.
Is Eva Morava-Kozicz, MD, PhD currently recruiting for clinical trials?
No, Eva Morava-Kozicz, MD, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Eva Morava-Kozicz, MD, PhD has studied deeply?
Yes, Eva Morava-Kozicz, MD, PhD has studied treatments such as Epalrestat, Placebo.
What is the best way to schedule an appointment with Eva Morava-Kozicz, MD, PhD?
Apply for one of the trials that Eva Morava-Kozicz, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.